Online citations, reference lists, and bibliographies.
← Back to Search

Early Contrast Enhancement: A Novel Magnetic Resonance Imaging Biomarker Of Pleural Malignancy

S. Tsim, C. Humphreys, G. Cowell, D. Stobo, Colin Noble, R. Woodward, C. Kelly, L. Alexander, J. Foster, C. Dick, K. Blyth
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Highlights • A novel MRI biomarker of pleural malignancy is described – Early Contrast Enhancement.• Early Contrast Enhancement is a semi-objective, perfusion-based biomarker.• Early Contrast Enhancement can be measured in patients with minimal pleural thickening.
This paper references
10.1002/jmri.22372
Imaging of the pleura
E. J. Helm (2010)
10.1016/j.rmed.2008.07.021
Talc pleurodesis: evidence of systemic inflammatory response to small size talc particles.
E. Genofre (2009)
10.1007/s40846-016-0163-7
Pattern Recognition Approaches for Breast Cancer DCE-MRI Classification: A Systematic Review
R. Fusco (2016)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.2214/AJR.13.12412
CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
Avinash R Kambadakone (2015)
10.2214/AJR.13.11888
Dynamic contrast-enhanced CT and MRI for pulmonary nodule assessment.
Y. Ohno (2014)
10.1378/chest.14-0820
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. M. Porcel (2015)
10.1016/S0009-9260(97)80328-5
Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
S. Mussurakis (1997)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.5271/SJWEH.378
Magnetic resonance appearance of asbestos-related benign and malignant pleural diseases.
P. Boraschi (1999)
Diagnostic accuracy of 18 FFDGPET and PET / CT in the di ff erential diagnosis between malignant and benign pleural lesions
R. Sadeghi G. Treglia (2014)
10.1259/bjr/55980445
Multidetector CT imaging of pleura: comparison of two contrast infusion protocols.
V. Raj (2011)
10.1034/J.1600-0455.2001.420511.X
Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma.
A. Knuuttila (2001)
Dynamic contrastenhanced MRI for the detection of prostate cancer : meta - analysis , AJR
C. H. Tan (2015)
10.1371/journal.pone.0079911
Correlation between CT Perfusion Parameters and Microvessel Density and Vascular Endothelial Growth Factor in Adrenal Tumors
H. Qin (2013)
10.1097/RLU.0b013e3181bece11
F-18 FDG PET/CT Characterization of Talc Pleurodesis-Induced Pleural Changes Over Time: A Retrospective Study
N. Nguyen (2009)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1148/RADIOL.2331031535
Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density.
C. Yi (2004)
10.1016/J.CRAD.2005.05.015
Use of imaging in the management of malignant pleural mesothelioma.
R. Benamore (2005)
Dzik - Jurasz , Perfusion MR imaging of extracranial tumor angiogenesis , Top
A. A. R. Padhani (2010)
10.2214/AJR.10.4665
3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
Riham H. El Khouli (2011)
10.21037/jtd.2017.07.86
The value of delayed phase enhanced imaging in malignant pleural mesothelioma.
Akash M Patel (2017)
10.1002/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D
EVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA
S. Kumar-Singh (1997)
Pleural Guideline Group , Investigation of a unilateral pleural e ff usion in adults : british thoracic society pleural disease guideline
Y. C. G. Lee C. Hooper (2010)
10.1378/CHEST.118.3.604
MRI and CT in the differential diagnosis of pleural disease.
J. Hierholzer (2000)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A. ADoefaa (2003)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
10.1515/9783111438443-006
N
Città DI Torino (1824)
10.1053/j.semtcvs.2009.06.011
Current trends in radiologic management of malignant pleural mesothelioma.
R. Gill (2009)
10.1054/bjoc.2001.1997
Angiogenesis is an independent prognostic factor in malignant mesothelioma
J. Edwards (2001)
10.1056/NEJM197111182852108
Tumor angiogenesis: therapeutic implications.
J. Folkman (1971)
10.1016/j.lungcan.2016.11.010
The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy
S. Tsim (2017)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1136/thx.2010.136978
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
C. Hooper (2010)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
10.1183/16000617.0063-2016
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
A. Bibby (2016)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1148/radiol.10100245
Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT.
Y. Ohno (2011)
10.2214/AJR.166.4.8610582
Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease.
F. Falaschi (1996)
10.1159/000356752
Positive FDG-PET/CT of the Pleura Twenty Years after Talc Pleurodesis: Three Cases of Benign Talcoma
T. Vandemoortele (2014)
10.1016/j.lungcan.2013.08.005
Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
S. Armato (2013)
CT in di ff erential diagnosis of di ff use pleural disease , AJR
A. N. Leung (2010)
Evaluation of pleural disease using MR and CT , Acta Radiol
L. Kivisaari A. Knuuttila (2001)
10.1378/CHEST.129.6.1570
Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.
F. Giesel (2006)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
[Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
F. Falaschi (1996)
10.1136/thoraxjnl-2014-206054
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
10.1016/j.acra.2013.09.015
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
G. Treglia (2014)
10.1515/9783111419787-003
H
Yu-Qin Cao (1824)
10.1016/j.remn.2011.06.002
The role of FDG PET-CT in differential diagnosis of pleural pathologies.
U. Elboğa (2012)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
Diagnostic accuracy of 18 FFDGPET and PET / CT in the di ff erential diagnosis between malignant and benign pleural lesions : a systematic review and meta - analysis
R. Sadeghi G. Treglia (2014)
10.1164/AJRCCM.162.3.9911010
Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis.
W. Matsuyama (2000)
10.1515/9783111413426-022
U
Lan Ma (1824)
10.1016/j.acra.2007.12.014
Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34).
F. Giesel (2008)
10.1136/bmjopen-2016-013324
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study
S. Tsim (2016)
10.2214/AJR.11.8476
CT perfusion in oncologic imaging: a useful tool?
R. García-Figueiras (2013)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
10.1067/j.cpradiol.2015.02.010
Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis.
R. García-Figueiras (2015)
10.1378/CHEST.125.6.2156
Vascular endothelial growth factor levels in active pulmonary tuberculosis.
F. Alataş (2004)
10.1016/J.EJRAD.2007.08.010
Morphologic and functional imaging of malignant pleural mesothelioma.
M. Yamamuro (2007)
10.1016/S0720-048X(99)00012-1
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review.
K. Miles (1999)
10.1016/b978-0-323-37753-9.50110-9
Malignant pleural mesothelioma.
V. G. Nadgouda (2001)
10.1097/00002142-200402000-00005
Perfusion MR Imaging of Extracranial Tumor Angiogenesis
A. Padhani (2004)
10.1016/S0720-048X(01)00426-0
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
M. Metintas (2002)
Dynamic contrastenhanced CT and MRI for pulmonary nodule assessment , AJR
M. Nishio (2014)
10.1515/9783111548050-024
M
M. Sankar (1824)
10.7150/jca.2586
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
G. Genestreti (2012)
10.2214/AJR.14.13373
Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.
Cher Heng Tan (2015)
10.2214/AJR.11.8267
Perfusion MDCT of prostate cancer: correlation of perfusion CT parameters and immunohistochemical markers of angiogenesis.
M. Osimani (2012)
10.1007/s00330-013-3053-1
Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging
J. Coolen (2013)
Di ff erentiation of malignant and benign pulmonary nodules with quantitative fi rstpass 320detector row perfusion CT versus FDG PET / CT
H. Koyama Y. Ohno (2011)
Bluemke , 3T dynamic contrastenhanced MRI of the breast : pharmacokinetic parameters versus conventional kinetic curve analysis , AJR
R. H. El Khouli (2011)
10.1097/RLI.0b013e3181817b3d
Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results
C. Plathow (2008)



This paper is referenced by
10.1007/s13665-020-00257-9
Pulmonary MRI: Applications and Use Cases
Raza Mushtaq (2020)
10.1016/j.lungcan.2020.09.025
A comparison between MRI and CT in the assessment of primary tumour volume in mesothelioma.
S. Tsim (2020)
10.1016/j.crad.2019.12.001
The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.
S. Sinha (2020)
10.1136/bmjresp-2018-000293
Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion
Geoffrey A Martin (2018)
10.1016/j.jtho.2019.08.2506
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.
A. Nicholson (2019)
10.1016/j.jtho.2019.08.012
Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T
R. Gill (2019)
10.1007/978-3-030-16884-1_9
Diagnostic Imaging of Mesothelioma
C. Straus (2019)
10.1016/j.cllc.2020.06.002
Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.
Akash M Patel (2020)
10.21037/CCTS-20-41
When magnetic resonance imaging is needed: malignant pleural mesothelioma with transdiaphragmatic infiltration and localized appearance: a case report
Raphael Werner (2020)
10.1183/2312508x.10023619
Optimal diagnosis and treatment of malignant pleual disease: challenging the guidelines
D. Arnold (2020)
Semantic Scholar Logo Some data provided by SemanticScholar